Skip to content

Valneva

  • Über uns
    Über uns Advancing vaccines for better lives Mehr lesen
    • Unsere Strategie
    • Unsere Verantwortung
    • Unser Team
  • Produkte
    Produkte Focusing on vaccines for infectious diseases with major unmet needs Mehr lesen
    • Japanische Enzephalitis-Impfstoff
    • Cholera-Impfstoff
    • COVID-19 Impfstoff
    • Marketing und Vertrieb
    • Produktion und Dienstleistungen
  • F&D
    F&D Dedicated to innovation in vaccine research and development Mehr lesen
    • Pipeline
    • Lyme Borreliose – VLA15
    • Chikungunya – VLA1553
    • Zika – VLA1601
    • Clostridium Difficile – VLA84
    • Expanded Access-Richtlinie
    • Wissenschaftliche Publikationen
  • Investoren
    Investoren Mehr lesen
    • Events und Präsentationen
      • Kalender
      • Präsentationen des Unternehmens
    • Financial & Filings
      • Finanzberichte
      • SEC Filings
    • Pressemeldungen
    • Corporate Governance
      • Corporate Governance
      • Corporate Compliance & Ethics
    • Vorgeschriebene Informationen
    • Aktieninformation
      • Aktienkurs
      • Analysten
      • Aktionärsstruktur
      • Delisting von der Wiener Börse
    • Hauptversammlungen
      • 2022 Kombinierte Hauptversammlung
      • June 23, 2022 Special Meeting
      • Archiv Hauptversammlungen
    • Videos und Webcasts
    • Häufig gestellte Fragen
    • Kontakt
  • Medien
    Medien Pressemeldungen, Aktuelles und Ressourcen für Medien Mehr lesen
    • Pressemeldungen
    • In den Nachrichten
    • Ressourcen für Medien
    • Medienkontakte
  • Karriere
Kontakt
  • EN
  • FR
  • | DE
Search

VIVALIS GRANTS RIGHTS TO EBx® CELL LINE FOR TESTING IN PRODUCTION OF VIRAL VACCINES

June 18, 2008

Thank you for applying for:

VIVALIS GRANTS RIGHTS TO EBx® CELL LINE FOR TESTING IN PRODUCTION OF VIRAL VACCINES







    I hereby confirm that I have read and understood the data privacy declaration.*

    * Indicated required field

    Data privacy declaration

    Valneva

    • Über uns
    • Produkte
    • F&D
    • Investoren
    • Medien
    • Karriere
    Weitere Websites
    • Valneva Canada
    • Valneva UK
    • Valneva Austria
    • Valneva USA
    • Valneva Nordic
    • Valneva France
    Kontakt
    © 2023 Valneva SE. All rights reserved.
    • Legal Notice
    • Cookie Policy
    • Privacy Policy
    • Terms of Use
    • 1907-00-VLA-002 | 11-JUL-2019
    We use cookies to improve the functionality and user experience of the website and to analyse the traffic. You can find detailed information in our Privacy Policy.
    ACCEPT CHANGE MY PREFERENCES
    Privacy & Cookies Policy

    Your privacy is important to us

    Cookies are very small text files that are stored on your computer when you visit a website. We use cookies for a variety of purposes and to enhance your online experience on our website (for example, to remember your account login details).

    You can change your preferences and decline certain types of cookies to be stored on your computer while browsing our website. You can also remove any cookies already stored on your computer, but keep in mind that deleting cookies may prevent you from using parts of our website.

    More information

    For any queries in relation to our policy on cookies and your choices, please contact us.

    To find out more, please visit our Cookies Policy.
    Strictly necessary cookies
    Always Enabled
    These cookies are essential to provide you with services available through our website and to enable you to use certain features of our website.

    Without these cookies, we cannot provide you certain services on our website.
    Tracking and performance cookies
    These cookies are used to collect information to analyze the traffic to our website and how visitors are using our website.

    For example, these cookies may track things such as how long you spend on the website or the pages you visit which helps us to understand how we can improve our website site for you.

    The information collected through these tracking and performance cookies do not identify any individual visitor.
    SAVE & ACCEPT